Summer School in Translational Cancer Research, October 16 – 22, 2022, Portugal

The CCE Summer School in Translational Cancer Research is intended to provide an in-depth training of scientists and clinicians to gain a cross-disciplinary knowledge of areas of the entire cancer research continuum.

We thank the Scientific Committee, all speakers and all participants for their contributions and for making the CCE Summer School 2022 a great success! We would also like to thank our supporters: the German Cancer Consortium (DKTK), the Cancer Prevention Europe consortium (CPE) and Molecular Oncology.

Sixty-four ambitious doctoral and postdoctoral researchers as well as clinician scientists from twelve countries and twenty-nine international speakers met at the beautiful hotel Porto Bay Falesia in Portugal.

The discussed research focused on personalized approaches to cancer medicine for a wide variety of cancer entities. Topics included immunotherapy, digital oncology and artificial intelligence, imaging, nutrition and physical activity in cancer prevention as well as ethics and health economics. This was complemented by workshops on clinical decision support systems, how to set up clinical trials, and project-, self- and career-management.


  • Giovanni Apolone, Instituto Nazionale dei Tumori di Milano, Doing research in the Real World: what we learned from COVID 19
  • Richard Baird, Cancer Research UK Cambridge Centre, University of Cambridge: Workshop on Clinical Decision Support and MTB
  • Fabrice Barlesi, Institute Gustave Roussy, Villejuif, Precision immuno-oncology for advanced non-small cell lung cancer patients
  • Jonas Bergh, Karolinska Institutet, Stockholm, Precision Medicine for cancer patients – yesterday and tomorrow
  • Benjamin Besse, Goustave Roussy, France, Immunotherapy
  • Elena Ioana Braicu, Charité – University Hospital Berlin, Personalized treatment in ovarian cancer in the clinical routine – are we there yet?
  • Irene Braña, Vall d’Hebron Institute of Oncology, Barcelona: Workshop How to set up clinical trials
  • Mario Paolo Colombo, Instituto Nazionale dei Tumori di Milano, Immune function of extracellular matrix in TME and bone marrow
  • George Coukos, Ludwig Institute for Cancer Research, Lausanne: Adoptive T cell therapy using TILs and lessons from the tumor microenvironment
  • Jérome Foucaud, Institut National du Cancer, Boulogne-Billancourt, European Cancer Burden: Perspective in Primary Prevention
  • Stefan Fröhling, German Cancer Research Center & National Center for Tumor Diseases, Heidelberg, Biology-Guided Precision Medicine in Rare Cancers
  • Dirk Jäger, University Hospital Heidelberg & National Center for Tumor Diseases, Heidelberg, Individualizing immunotherapy
  • Ellen Kampman, Wageningen University & Research: The role of diet, nutrition and body composition in primary and tertiary cancer prevention.
  • Jakob Kather, Technical University of Dresden and German Cancer Consortium (DKTK), Artificial intelligence-based biomarkers in precision oncology
  • Frederick Klauschen, Ludwig Maximilians University Munich and German Cancer Consortium (DKTK), AI in cancer research and diagnostic pathology
  • Svetlana Lagercrantz, Karolinska University Hospital & Karolinska Insitutet, Srockholm: Hereditary breast cancer – treatment and prevention
  • Janne Lethiö, Karolinska Institutet, Sweden: Next generation cancer precision medicine by proteomics
  • Ana Teresa Maia, University of Algarve: Gene regulation in Breast Cancer
  • Daniel Mertens, German Cancer Research Center & at the University of Ulm: Workshop on Project Management and Career Development
  • Delia Mezzanzanica, Instituto Nazionale dei Tumori di Milano, Clinical trials: the added value of translational research
  • Päivi Östling, SciLifeLab, Karolinska Institutet, Stockholm, Functional Precision Medicine (fPM)
  • Carla Oliveira, Instituto de Investigação e Inovação em Saúde, University of Porto, Hereditary Gastric Cancer: Clinical and molecular aspects
  • Wim Oyen, Humanitas University in Milan and Rijnstate Hospital, Arnhem, Molecular Imaging and Theranostics in Oncology
  • Raquel Pérez-López, Vall d’Hebron Institute of Oncology, Barcelona, AI in medical imaging for developing new cancer biomarkers
  • Michael Schlander, German Cancer Research Center & University of Heidelberg, Health economics
  • Karen Steindorf, German Cancer Research Center: The role of physical activity in primary and tertiary cancer prevention.
  • David Tamborero, Karolinska Institutet, Stockholm: Workshop on Clinical Decision Support and MTB
  • Emile Voest, Netherlands Cancer Institute, Amsterdam, On the cross roads of translational research and computational science: making impact
  • Eva Winkler, National Center for Tumor Diseases and University hospital of Heidelberg, Patient involvement and Ethics


  • Precision Medicine
  • Immunooncology
  • Cancer Prevention
  • AI/Digital Oncology
  • Imaging/Radiomics
  • Breast Cancer
  • Tumor Microenvironment
  • Patient Involvement & Ethics
  • Trials/Early Phase Therapies
  • Health Economy
  • Clinical Decision Support Systems and the CCE Molecular Tumor Board
  • Workshop How to set up clinical trials
  • Workshop on Project Management and Career Development